The IWMF is partnering with CancerCare to offer a CancerCare Connect® Education Workshop on Waldenstrom’s macroglobulinemia on Wed., January 11, 2017.
Linda Nelson, DMD is the newest member of the Board of Trustees. Her medical background and experience editing scientific publications will be of benefit to the IWMF community.
Please visit our Publications webpage for five new, downloadable Treatment Options Guides, now available in seven languages.
On November 15, 2016, the IWMF issued a new RFP to 250 of the leading WM researchers in the world. This RFP was developed together with Leukemia & Lymphoma Society (LLS).
Watch presentations regarding the latest research and clinical treatment approaches to WM as presented at the 2016 IWWM9 International Doctor-Patient Forum.
To better serve our members, support groups, affiliates and partners, we have strengthened the IWMF Office by adding an Operations Manager.
Ron Ternoway was diagnosed with WM in 2006. After multiple treatments, most with short remissions, in 2014 Ron decided to participate in a Clinical Trial.
Bing-Neel is an extremely rare complication of WM. For those who missed the inspirational story about Julie Davidson’s journey with Bing-Neel in the September, 2016 issue of the Torch, you can read it here in English or Spanish.
The 170 attendees at the IWWM9 Doctor-Patient Forum in Amsterdam came from Western and Eastern Europe, Central America, Australia, Canada, and the US.
The IWMF is pleased to congratulate the 11 young investigators recognized at the 9th International Workshop on WM (IWWM9) on October 5-8, 2016, in Amsterdam, The Netherlands.